Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-(6-acetyl-3-(3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy)-2-propylphenoxy)butyric Acid
2. Kca 757
3. Kca-757
4. Kca757
5. Mn 001
6. Mn-001
7. Mn001 Cpd
1. 125961-82-2
2. Kca 757
3. Kca-757
4. Mn-001
5. Kca757
6. Mn-001 (tipelukast)
7. Kca 757;mn 001
8. Tipelukast (usan)
9. Tipelukast [usan]
10. 08379p260o
11. 4-(6-acetyl-3-(3-((4-acetyl-3-hydroxy-2-propylphenyl)thio)propoxy)-2-propylphenoxy)butanoic Acid
12. Butanoic Acid, 4-[6-acetyl-3-[3-[(4-acetyl-3-hydroxy-2-propylphenyl)thio]propoxy]-2-propylphenoxy]-
13. Tipelukast [usan:inn]
14. Mn 001 (pharmaceutical)
15. Unii-08379p260o
16. 4-(6-acetyl-3-(3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy)-2-propylphenoxy)butyric Acid
17. 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric Acid
18. Butanoic Acid, 4-(6-acetyl-3-(3-((4-acetyl-3-hydroxy-2-propylphenyl)thio)propoxy)-2-propylphenoxy)-
19. Mn 001
20. Tipelukast [inn]
21. Tipelukast [mart.]
22. Tipelukast [who-dd]
23. 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenyl)sulfanylpropoxy]-2-propylphenoxy]butanoic Acid
24. Butanoic Acid,4-[6-acetyl-3-[3-[(4-acetyl-3-hydroxy-2-propylphenyl)thio]propoxy]-2-propylphenoxy]-
25. Schembl154898
26. Chembl2104988
27. Dtxsid00925325
28. Chebi:177735
29. Bcp17000
30. Zinc3796820
31. Akos015914770
32. Cs-6822
33. Db12435
34. Sb17439
35. Hy-14938
36. D06659
37. 961t822
38. L001366
39. Q27236352
40. Kca-757; Mn-001; Kca757; Mn001; Kca 757; Mn 001
41. 4-(6-acetyl-3-{3-[(4-acetyl-3-hydroxy-2-propylphenyl)sulfanyl]propoxy}-2-propylphenoxy)butanoic Acid
42. 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propyl-phenylthio)propoxy]-2-propylphenoxy]butyric Acid
43. 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenyl)sulanylpropoxy]-2-propylphenoxy]butanoic Acid
| Molecular Weight | 530.7 g/mol |
|---|---|
| Molecular Formula | C29H38O7S |
| XLogP3 | 6.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 17 |
| Exact Mass | 530.23382472 g/mol |
| Monoisotopic Mass | 530.23382472 g/mol |
| Topological Polar Surface Area | 135 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 714 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Tipelukast manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tipelukast, including repackagers and relabelers. The FDA regulates Tipelukast manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tipelukast API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tipelukast supplier is an individual or a company that provides Tipelukast active pharmaceutical ingredient (API) or Tipelukast finished formulations upon request. The Tipelukast suppliers may include Tipelukast API manufacturers, exporters, distributors and traders.
Tipelukast Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tipelukast GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tipelukast GMP manufacturer or Tipelukast GMP API supplier for your needs.
A Tipelukast CoA (Certificate of Analysis) is a formal document that attests to Tipelukast's compliance with Tipelukast specifications and serves as a tool for batch-level quality control.
Tipelukast CoA mostly includes findings from lab analyses of a specific batch. For each Tipelukast CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tipelukast may be tested according to a variety of international standards, such as European Pharmacopoeia (Tipelukast EP), Tipelukast JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tipelukast USP).
LOOKING FOR A SUPPLIER?
